CYP2C19 Genetic Polymorphism, Rabeprazole and Esomeprazole Have No Effect on the Anti-Platelet Action of Clopidogrel

被引：0
|
作者：
El-Halabi, Mustapha [1 ]
Malli, Ahmad [1 ]
Mansour, Nabil [1 ]
Ghaith, Ola [1 ]
Saab, Rayan [1 ]
Mahfouz, Rami [1 ]
Alam, Samir [1 ]
Zgheib, Nathalie [1 ]
Sharara, Ala [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2012年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
120
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [21] CYP2C19 gene polymorphism and platelet responsiveness to clopidogrel in Korean patients with ischemic stroke
    Lee, H. C.
    Lee, B. C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 880 - 880
  • [22] Rabeprazole Can Overcome the Impact of CYP2C19 Polymorphism on Quadruple Therapy
    Kuo, Chao-Hung
    Wang, Sophie S. W.
    Hsu, Wen-Hung
    Kuo, Fu-Chen
    Weng, Bi-Chuang
    Li, Chia-Jung
    Hsu, Ping-I
    Chen, Angela
    Hung, Wen-Chun
    Yang, Yuan-Chieh
    Wang, Wen-Ming
    Wu, Deng-Chyang
    HELICOBACTER, 2010, 15 (04) : 265 - 272
  • [23] Prevalence and types of genetic polymorphisms of CYP2C19 and their effects on platelet aggregation inhibition by clopidogrel
    Aga, Q. A. A.
    Hasan, M. K.
    Nassir, K. F.
    Aga, L. A. A.
    Al-Jaidi, B. A.
    Aldhoun, M.
    Morsy, M. A.
    Nair, A. B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 11286 - 11294
  • [24] Role of CYP2C19 pharmacogenetic polymorphism on response of esomeprazole in the treatment of GERD
    Halimi, Shafarul
    Abu Hassan, Muhammad Radzi
    Ismail, Rusli
    Kiew, Kuang Kiat
    Zainuddin, Zalwani
    Mustapha, Mohd Nazri
    Mokhtar, Suraya
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 67 - 68
  • [25] Proton Pumps Inhibitors and Clopidogrel Interaction: Effect of Rabeprazole on the Anti-Platelet Function of Clopidogrel in Relation to CYP2C19 Genotype Status. A Prospective, Randomized, 3-way Crossover PK/PD Study in Healthy Subjects
    Coudsy, Bogdana
    Funck-Brentano, Christian
    Blanchard, Anne
    Frank, Michael
    Szymezak, Jean
    Remones, Veronique
    Verhaeghe, Tom
    Solanki, Bhavna
    Molimard, Mathieu
    Ducint, Dominique
    Azizi, Michel
    Gaussem, Pascale
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S13 - S13
  • [26] Physiologically Based Pharmacokinetic Modeling for Sequential Metabolism: Effect of CYP2C19 Genetic Polymorphism on Clopidogrel and Clopidogrel Active Metabolite Pharmacokinetics
    Djebli, Nassim
    Fabre, David
    Boulenc, Xavier
    Fabre, Gerard
    Sultan, Eric
    Hurbin, Fabrice
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (04) : 510 - 522
  • [27] CYP2C19 genetic polymorphism in the Vietnamese population
    Nhung Phuong Vu
    Hoa Thi Thanh Nguyen
    Ngoc Thi Bich Tran
    Ton Dang Nguyen
    Hue Thi Thu Huynh
    Xuan Thi Nguyen
    Duong Thuy Nguyen
    Hai Van Nong
    Ha Hai Nguyen
    ANNALS OF HUMAN BIOLOGY, 2019, 46 (06) : 491 - 497
  • [28] The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease
    El-Khodary, N. M.
    El-Behery, A. M.
    El-Askary, N. A.
    Donia, H. M.
    Omran, G. A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (19) : 6065 - 6076
  • [29] Genetic polymorphism of CYP2C19 in Maharashtrian population
    Yogita Ghodke
    Kalpana Joshi
    Yashendra Arya
    Anjali Radkar
    Aditi Chiplunkar
    Pooja Shintre
    Bhushan Patwardhan
    European Journal of Epidemiology, 2007, 22 : 907 - 915
  • [30] Genetic polymorphism of CYP2C19 in Maharashtrian population
    Ghodke, Yogita
    Joshi, Kalpana
    Arya, Yashendra
    Radkar, Anjali
    Chiplunkar, Aditi
    Shintre, Pooja
    Patwardhan, Bhushan
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2007, 22 (12) : 907 - 915
12345